Philly's accelerator DreamIt Health announces first startups to enter its boot camp

Independence Blue Cross (IBC), Penn Medicine and DreamIt Ventures announced the 10 healthcare startup companies selected to participate in DreamIt Health, a Philadelphia-based healthcare accelerator. The 2013 DreamIt Health inaugural class will enter a four-month boot camp, beginning April 8, to help rapidly advance the development of their innovative healthcare solutions and business models. 

Sponsored by IBC and Penn Medicine, DreamIt Health launched in December 2012 with a nationwide search for unique healthcare startups who apply technology to the challenges of keeping people healthy and providing more effective and affordable interventions at the point of care.

IBC, Penn Medicine and DreamIt Ventures selected the 10 participating companies based on the strength of their founders and their entrepreneurial passion, and the level of innovation in their products or services. Each startup will receive a stipend of up to $50,000. During the four-month boot camp, they will receive in-depth mentoring and coaching from experienced entrepreneurs and healthcare executives, and access to information and guidance from IBC, Penn Medicine and others to help develop their products. Additionally, the companies will be provided workspace at Venturef0rth in Philadelphia and have an opportunity to test their business models with potential customers.

The 10 selected companies are:

AirCare: a mobile application that helps hospitals prevent readmissions and improve patient outcomes through telenursing and patient-specific analytics.

Biomeme: a low-cost, mobile molecular diagnostics device to help point-of-care clinicians and epidemiologists quickly diagnose and track infectious diseases in real-time with smartphones.

Fitly: a service that helps health plans tackle the childhood obesity epidemic by engaging and motivating at-risk families with game dynamics and convenient delivery of health ingredients.

Grand Round Table: an application that helps clinicians rapidly zero in on the right diagnosis for complex cases by intelligently matching the patient’s electronic record against millions of other cases drawn from around the world.

Medlio: a mobile application that enables physicians to get paid faster and eliminates paper sign-in forms through a virtual health insurance ID card that instantly syncs the right information among patient, provider and payer at point-of-care.

OnShift: the next-generation of healthcare communication systems that help hospitals improve patient outcomes through instant communications among clinicians caring for the same patient and analytics to discover and remove obstacles to effective care delivery and transitions-in-care.

Osmosis: a learning management system that helps medical institutions produce clinicians who better retain and apply knowledge via a web and mobile platform that takes advantage of cutting-edge cognitive techniques.

MemberRx: a solution to better contain the cost of pharmaceuticals by enabling selection of the best generic or on-formulary branded drug for a specific patient seamlessly with an electronic medical record system.

SpeSo Health: an online analytics platform for identifying and accessing top medical expertise in rare and complex diseases.

Stat: a web and mobile application that helps providers and payers speed patient transport and lower costs by matching and dispatching idle transportation resources.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.